American Association for the Study of Liver Diseases AASLD The Liver Meeting 2021 (Videos)

Our Attendees Include:

• Adult and pediatric hepatology experts.
• Clinical, basic, and translational researchers.
• Specialists who diagnose and treat liver disease, including gastroenterologists, surgeons, clinical pathologists, anesthesiologists, and radiologists.
• Primary care physicians.
• Nurse practitioners, registered nurses, physician assistants, pharmacists, and other allied health professionals in hepatology and the disciplines listed above.
• Trainees, and students in the disciplines listed above.
• Patient advocates and patients.

Topics : 

– 2021 Academic Debates

– AASLD & AASLD Foundation Awards & Honors Ceremony

– AASLD Distinguished Award

– AASLD_ALEH Joint Symposium

– AASLD_ASGE Endoscopy Course Live Q&A Session

– AASLD_ILTS Transplant Course Live Q&A Session

– Alcohol, Cancer, Fibrosis Cirrhosis Portal Hypertension

– Alcohol, NASH and NAFLD

– Alcohol-associated Liver Disease

– Associates, Health Outcomes, Fibrosis Cirrhosis Portal Hypertension, TransplantLiver Failure

– Basic Translational Science, Microbiome Genomics Personalized Medicine

– Basic Science Debrief

– Cancer, Transplant Liver Failure, NASH and NAFLD

– Career Development Workshop

– Cholestatic and Autoimmune Liver Diseases

– Cirrhosis Improving Quality through Patient Empowerment

– Clinical Hepatology Debrief

– Clinical Research Workshop – Part I

– Clinical Research Workshop – Part II

– COVID-19 and the Liver Symposium

– Diversity Workshop

– Emerging Trends Symposium

– Fibrosis Cirrhosis Portal Hypertension, TransplantLiver Failure, Pediatric

– Grit, Grace, Gratitude, and Resilience What You Wish Your Doctors Knew About You

– HBV Cure How Close Are We

– HBV Global Symposium

– Health Outcomes, Fibrosis Cirrhosis Portal Hypertension, TransplantLiver Failure, NASH and NAFLD

– Health Outcomes, Public Health

– Health Outcomes, Training and Career Development, Public Health

– Hepatitis B

– Hepatitis C

– Hepatitis Debrief

– Hepatology Associates

– Hepatotoxicity SIG

– Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture

– Leon Schiff State-of-the-Art Lecture

– Liver Cancer

– Liver Cell Biology

– Liver Fibrosis

– Liver Transplantation and Surgery SIG

– Making an Impact Where You Are Patient Voices as a Vehicle for Change

– Microbiome Genomics Personalized Medicine

– NAFLD Debrief

– Nonalcoholic Fatty Liver Disease

– Nutrition 101 for Patients with Chronic Liver Disease

– Panel Discussion Saving More Lives Forward from “A Burden of Genius”

– Parallel 1 Advances with Approved HBV Therapies

– Parallel 2 Health Services and Public Health

– Parallel 3 Metabolic and Genetic Disease Hemochromatosis, Wilsons Disease, Alpha-1 Antitrypsin Deficiency

– Parallel 4 COVID-19 Clinical

– Parallel 5 Pediatric Hepatology Metabolic and Genetic Diseases

– Parallel 6- Experimental and Translational Portal Hypertension and ACLF – The World’s Premier Event in Hepatology

– Parallel 7 Immunosuppression, Outcomes, Complications

– Parallel 8 HBV Cascade of Care, Natural History and Diagnostics

– Parallel 9 COVID-19 Translational and Clinical

– Parallel 10 Diagnostics and Biomarkers of NAFLD

– Parallel 11 Healthcare Quality and Access in Hepatology

– Parallel 12 Donor and Allocation Issues, Living and Split Donor Liver Transplantation

– Parallel 13 Novel HBV Therapies and Approaches

– Parallel 14 Hepatitis C Oral Session

– Parallel 15 Biomarkers and Therapeutics in Autoimmune and Cholestatic Diseases

– Parallel 16 Experimental and Translational Advances in Alcohol-Associated Liver Disease

– Parallel 17 NAFLD and NASH Predicting Outcomes and Response to Interventions

– Parallel 18 Mechanisms of Cholestatic Liver Injury

– Parallel 19 Clinical Advances in Alcohol-Associated Liver Disease

– Parallel 20 Hepatobiliary Neoplasia Clinical Oral Session

– Parallel 21 NAFLD and NASH Clinical Trials of Novel Therapeutics

– Parallel 22 Portal Hypertension Risk Stratification and Treatment for Varices

– Parallel 23 Cell and Molecular Biology

– Parallel 24 Hepatobiliary Neoplasia Experimental Translational Oral Session

– Parallel 25 Portal Hypertension Clinical

– Parallel 26 Liver Fibrogenesis and Non-Parenchymal Cell Biology

– Parallel 27 Diversity, Equity, and Inclusion in Liver Disease Care

– Parallel 28 Gut Liver Axis and Microbiome

– Parallel 29 NAFLD and NASH Management and Outcomes in the Clinic

– Parallel 30- Genomics and Precision Medicine – The World’s Premier Event in Hepatology

– Parallel 31 Clinical Translational Research in Pediatric Hepatology

– Parallel 32 Clinical Acute on Chronic Liver Failure

– Parallel 34 Basic Science Research in Pediatric Hepatology

– Parallel 35 Viral Hepatitis Oral Session (Non-HBV, Non-HCV)

– Parallel 36 Hepatotoxicity

– Patient Annual Forum and Meet & Greet Networking

– Patient Debrief

– Patient Keynote How Physician-Patient Partnerships Can Improve Liver Disease Care & Research

– Pediatric Liver Disorders and Acute on Chronic Liver Failure SIG Program – Part I Management of Acute-on-Chronic Liver Failure in Adults and Children

– Pediatric Liver Disorders and Acute on Chronic Liver Failure SIG Program – Part II Management of Acute-on-Chronic Liver Failure in Adults and Children

– Pediatric, Cholestatic and Autoimmune Liver Disease

– Portal Hypertension Clinical and Experimental

– Postgraduate Course – Part I

– Postgraduate Course – Part II

– Postgraduate Course – Part III

– Postgraduate Course Live Q&A Session

– Practice Guidelines Debrief for Patients

– Practice Guidelines Workshop

– Presidential Plenary Basic and Translational

– Presidential Plenary Clinical and Translational

– Presidential Plenary Liver Transplant

– Presidential Welcome and President’s Choice Lecture

– Public Health Health Care Delivery

– The Liver Meeting Closing Remarks

– Transplant Surgery Workshop Part I (Increased-risk Organs)

– Transplant Surgery Workshop Part II (Living Donor, Split Liver)

– TransplantLiver Failure, Microbiome Genomics Personalized Medicine

– Viral Hepatitis Elimination Session

– Women’s Health Program

Release Date : November 13-16 2021